The First $100 Billion Drug

from Barron's Streetwise · host Barron's

BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Jan 6, 2023

Embed this episode

Attribution link and audio player

What this episode covers

BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time.

Distinct summary based on available episode metadata or transcript content.

Ready to play

The First $100 Billion Drug

0:00 21:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Peddlin' Pork with Patti’s Ann Martin A podcast dedicated to honoring the everyday challenges and triumphs of life in the restaurant industry at Patti’s 1880’s Settlement. See acast.com/privacy for privacy and opt-out information.

Frequently Asked Questions

How long is this episode of Barron's Streetwise?

This episode is 21 minutes long.

When was this Barron's Streetwise episode published?

This episode was published on January 6, 2023.

Can I download this Barron's Streetwise episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!